Ledger.Open graph →
SEC Form D · Amendment · filed February 1, 2018

Ultivue, Inc

Offering
$20.5M
Sold
$20.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Michael Natan · Cambridge, MAExec · DirectorPeng Yin · Cambridge, MADirectorAndrew Stevenson · Cambridge, MADirectorWen R. Chen · Cambridge, MADirectorDavid R. Walt · Cambridge, MADirectorLian Y. Chen · Cambridge, MADirectorKeith Crandell · Cambridge, MADirectorJeffrey Weber · Wenatchee, WADirectorBruce M. Dickson · Dallas, TXDirectorZachary Aarons · New York, NYDirectorJames Chiboucas · Sonoma, CAExec · DirectorZak Schwarzman · New York, NYDirectorPermit Capital Advisors, LLC · WEST CONSHOHOCKEN, PADirectorJoan H. Fallon · NEW YORK, NYDirectorDaniel C. Wicker · DALLAS, TXExec · DirectorPatrick L. Howard · DALLAS, TXDirectorSteven B. Clapp · DALLAS, TXDirectorDarrell W. Cain · DALLAS, TXDirectorChristopher L. Beato · Broomfield, CODirectorJohan Brenner · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗